Cargando…
New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
Dementia is described as the fifth leading cause of death worldwide and Alzheimer’s disease (AD) is recognized as the most common, causing a huge impact on health costs and quality of patients’ lives. The main hallmarks that are commonly associated with the pathologic process are amyloid deposition,...
Autores principales: | Riscado, Micaela, Baptista, Bruno, Sousa, Fani |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471423/ https://www.ncbi.nlm.nih.gov/pubmed/34575473 http://dx.doi.org/10.3390/pharmaceutics13091397 |
Ejemplares similares
-
Alzheimer’s Disease Treatment: The Search for a Breakthrough
por: Reiss, Allison B., et al.
Publicado: (2023) -
mRNA, a Revolution in Biomedicine
por: Baptista, Bruno, et al.
Publicado: (2021) -
SOBA (soluble oligomer binding assay): A breakthrough or the early diagnosis of Alzheimer's disease
por: Sheikh, Ayesha, et al.
Publicado: (2023) -
Alzheimer’s research—breakthrough or breakdown?
por: Spires-Jones, Tara L
Publicado: (2021) -
The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer’s Disease
por: Sahlgren Bendtsen, Katja Maria, et al.
Publicado: (2023)